Literature DB >> 306076

Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis.

C L Schauf, V Schauf, F A Davis, M R Mizen.   

Abstract

In attempting to discover a relationship between the neurologic and immunologic abnormalities in multiple sclerosis, we found a serum factor that inhibits the ventral root response in isolated, perfused frog spinal cords. This effect is correlated with disease activity. Blocking activity of the serum was lost by heating to 56 degrees C, restored by adding complement, and was found in the serum IgG fraction. There was no correlation of neuroelectric blocking activity with measles complement-fixing antibody. An antibody other than that to measles virus may thus have a role in the pathogenesis of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306076     DOI: 10.1212/wnl.28.5.426

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.

Authors:  D A Compston; N M Milligan; P J Hughes; J Gibbs; V McBroom; B P Morgan; A K Campbell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

Review 2.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

3.  Rat CNS cell culture. Enhancement of neuronal survival and delay of glial proliferation by serum from patients with multiple sclerosis. A morphological study.

Authors:  G Savettieri; D Ferraro; A Chiarini; A Cestelli
Journal:  Ital J Neurol Sci       Date:  1984-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.